用 Mpox DNA 聚合酶对抗病毒相互作用进行计算研究
Harshit Tiwari1, Ashal Ilyas1, Pankaj Kumar Rai1
1Department of Biotechnology, Invertis University, Bareilly, India.
In silico pharmacology
|March 31, 2025
概括
两个新型抗病毒,DRAVPe01393和DRAVPe01399,显示出治疗Mpox的强大潜力. 这些有效抑制Mpox DNA聚合酶,为抗病毒治疗病毒提供了一个有希望的新途径.
科学领域:
- 病毒学 病毒学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 马波克斯病毒的DNA聚合酶 (DNA pol) 对于病毒复制至关重要,也是抗病毒干预的关键目标.
- 提供广泛的抗病毒活性,并正在作为治疗剂进行探索.
研究的目的:
- 以计算方式研究抗病毒和Mopox DNA聚合酶之间的分子相互作用.
- 为了确定Mopox DNA聚合酶的强抑制剂,以潜在的治疗开发.
主要方法:
- 选两个抗病毒数据库.
- 使用分子对接,分子动力学 (MD) 模拟和结合能量预测.
- 评估的稳定性,细胞透和结合亲和力.
主要成果:
- 确定了两个有前途的,DRAVPe01393和DRAVPe01399,来自针对DNA聚合酶的19个候选者.
- 这些体与Mopox DNA聚合物表现出稳定的相互作用和良好的细胞透潜力.
- 与基多福维二酸盐 (-10.79 kcal / mol) 相比,DRAVPe01399和DRAVPe01393的结合亲和度显著更高 (-60.86 kcal / mol和-47.92 kcal / mol).
结论:
- DRAVPe01393和DRAVPe01399是Mpox DNA聚合酶的强有力的抑制剂.
- 这些体代表了开发针对Mpox的新型抗病毒治疗的有希望的候选人.
- 这些发现有助于全球努力打击新出现的传染病Mpox.
更多相关视频
08:55Characterization of Multi-subunit Protein Complexes of Human MxA Using Non-denaturing Polyacrylamide Gel-electrophoresis
Published on: October 28, 2016
10.2K
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.1K
相关概念视频
Proofreading
6.1K
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase...
Errors During Replication are Corrected by the DNA Polymerase...
6.1K
DNA Base Pairing
26.6K
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
26.6K
